Dantrolene sodium (DAN) is widely used as a muscle relaxant drug for the treatment of malignant hyperthermia. 5-(4-Nitrophenyl)-2-furaldehyde is reported to be DAN-related compound C (DC), and it is the synthetic precursor of DAN that may be presented as process-related impurity in a pharmaceutical formulation. Also, it is considered to be the acidic and photolytic degradation product of DAN. The synthesis of DC has been performed from p-nitroaniline with good yield and high purity; structure elucidation has been confirmed by infrared (IR), mass spectrometry (MS), and nuclear magnetic resonance (NMR) analyses. In the present study, high-performance thin-layer chromatography (HPTLC) technique was developed and validated for the separation and quantification of DAN along with DC. Separation was carried out on HPTLC silica gel 60 F 254 plates using a developing system consisting of chloroform-ethylacetate-acetic acid (10:0.5:0.01, by volume) with ultraviolet (UV) scanning at 380 nm. The method was highly sensitive and could be used for the determination of DAN and DC in the range of 0.1-1.5 μg band −1 and 0.1-2.0 μg band −1 , respectively. The method has been validated in compliance with the International Conference on Harmonization (ICH) guidelines and was successfully applied to a pharmaceutical formulation. The method was compared favorably with the reported British Pharmacopoeia high-performance liquid chromatography (BP HPLC) method.
and multiple sclerosis [2] . It acts specifically and effectively on treating malignant hyperthermia [3] . DAN is a pharmacopeial drug in the United States Pharmacopeia (USP), the British Pharmacopoeia (BP), and the Japanese Pharmacopeia (JP) [4] . It was reported to have more than one related compounds including related compound C [5] which is chemically known as 5-(4-nitrophenyl)-2-furaldehyde ( Figure 1A ). This related compound was considered DAN synthetic precursor [6] . It was also reported to be the acidic and photolytic degradation product of DAN [7, 8] . After an extensive literature review, it was found that DAN has been analyzed in BP [1] , USP [5] , and JP [9] by a reversed-phase high-performance liquid chromatography (RP-HPLC) method. The drug was also determined by different HPLC [10] [11] [12] [13] [14] [15] and ultra-performance liquid chromatographic (UPLC) methods [7, 8] either in biological fluids, pharmaceutical formulation, or in the presence of its reported impurities or metabolites. In addition, the drug was determined in the presence of its metabolites by colorimetry [16] , pulse polarography [17] , and spectrophotofluorometry [18] . There is no report, however, on the synthesis of DC along with HPTLC technique for the separation and determination of DAN and DC. Our aim in this study was to prepare DC with high yield and purity using a simple preparation method and to develop and validate an HPTLC technique for the selective determination of DAN and DC. This method has advantages of being sensitive and less time-and money-consuming. It did not need high-cost chemicals or sample pretreatment steps. 7. Infrared (IR) spectra were made on a BRUKER Vector 22 (Japan) infrared spectrophotometer and were expressed in wavenumber (cm −1 ) using a potassium bromide disk.
Determination of Dantrolene Sodium in the Presence of Its Process-Related Impurity by High-Performance Thin-Layer Chromatography-Spectrodensitometry
8. Mass spectra were recorded on Finnigan MAT, SSQ 7000, mass spectrometer at 70 eV (EI).
9. IA 9100MK-Digital Melting Point Apparatus.
Materials

Pure Samples
Standard DAN was obtained from Sigma-Aldrich (St. Louis, MO, USA), with certified purity of 98%.
Pharmaceutical Formulation
Dantrelex ® capsules, batch No. 150728A, were manufactured by Chemipharm Pharmaceutical Industries (6th of October City, Egypt). Each tablet is claimed to contain 25 mg of DAN and was obtained from a local market.
Reagents
For the synthesis of dantrolene process impurity:
-p-Nitroaniline was obtained from Belami Fine Chemicals (Mumbai, India), with certified purity of 98%.
-Sodium nitrite was obtained from Loba Chemie (Mumbai, India), with certified purity of 97%.
-2-Furaldehyde was obtained from Sigma-Aldrich (St. Louis, MO, USA), with certified purity of 99%.
-CuCl 2 was obtained from Laboratory Rasayan (Anand, India), with certified purity of 99%.
-Acetone and absolute ethanol were obtained from El-Nasr Pharmaceutical Chemicals Company Abu-Zabaal (Cairo, Egypt).
For HPTLC:
All reagents and chemicals used were of analytical grade and include:
-Methanol HPLC grade (Tedia, Fairfield, OH, USA).
-Chloroform, HCl, ethyl acetate and glacial acetic acid (El-Nasr Pharmaceutical Chemicals Company Abu-Zabaal, Cairo, Egypt).
Solutions
Stock solutions at 0.5 mg mL −1 and 1.0 mg mL −1 in methanol were prepared for DAN and DC, respectively. Working solutions were prepared for each component in methanol having the concentration of 100.00 µg mL −1 . DAN stock and working solutions were stored at 5°C and protected from light.
Procedures
Synthesis of Dantrolene Process Impurity
5-(4-Nitrophenyl)-2-furaldehyde was synthesized as it is the key precursor for DAN as reported by Snyder et al. [6] . Synthesis steps are shown in Figure 1B . These steps are as follows:
1. Formation of nitro-phenyl diazonium chloride salt:
To a suspension of p-nitrophenol (1 g, 0.5 mole), 1.5 mL of conc. HCl was added and then heated until solid dissolved. An additional 3 mL of conc. HCl was added to stabilize the formed diazonium salt [19] . The solution was cooled to 0°C. A solution of (0.5 g, 0.5 mole) NaNO 2 was added dropwise and stirred for 30 min, and then diazonium salt was precipitated immediately.
Coupling of diazonium salt with 2-furaldehyde to produce DC:
To the formed diazonium salt, solution of 2-furaldehyde (0.695 g, 0.5 mole) in acetone was added, followed by addition of CuCl 2 (0.2 g) in aqueous solution as catalyst. The temperature was allowed to rise to 15-20°C. Solution was stirred for 4 h, and reddish brown precipitate was formed.
The obtained precipitate was filtered, washed with water, and recrystallized from absolute ethanol. The formed product was structurally elucidated by:
(a) Measuring melting point: by open capillary tube method using an IA 9100MK-Digital Melting Point Apparatus.
(b) Microanalysis includeing 1 H-NMR, IR, and mass spectroscopy.
HPTLC-Spectrodensitometric Determination of Dantrolene in the Presence of Its Process Impurity
Linearity and Construction of Calibration Curves
Aliquots equivalent to 1-15 μg mL −1 and 1-20 μg mL −1 of DAN and DC, respectively, were transferred from their working solution (100.00 μg mL −1 ), and 10 μL of each solution was applied in duplicate to HPTLC plates (20 cm × 10 cm) as bands with 5 mm width using a CAMAG Linomat IV applicator. The bands
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were spaced 5 mm from each other and 15 mm apart from the bottom edge of the plate. Linear ascending development was performed in a chromatographic chamber previously saturated with chloroform-ethyl acetate-glacial acetic acid (10:0.5:0.01, by volume) as the developing system for 30 min, at room temperature to a distance of 9 cm. The plates were air-dried and scanned at 380 nm using a slit dimension of 6.00 × 0.3 mm, Micro. The calibration curves for the studied components were constructed by plotting the integrated peak area × 10 −4 versus the corresponding concentrations, and the regression equation was computed.
Application to Pharmaceutical Formulations
The content of ten capsules of Dantrelax ® was accurately weighed and mixed. An accurately weighed portion equivalent to 50.00 mg of DAN was transferred into a 50-mL volumetric flask, and then, an amount of 25 mL methanol was added. The prepared solution was sonicated for 30 min, then cooled, and completed to volume with methanol. The solution was filtered and diluted to obtain a solution having a final concentration of 100.00 µg mL −1 .
Results and Discussion
In this work, the synthesis of DAN main impurity was achieved along with the determination of DAN. The first part of this work is concerned with simple, safe, and economic synthesis for DC, while the second part is to establish a sensitive, selective, accurate, and validated method for the quantitation of DAN in the presence of its process-related impurity, according to literature; only two UPLC methods have been reported for the determination of DAN in the presence of its related compound [7, 8] . In order to develop a simpler method that is available to be performed in quality control laboratories, an HPTLC technique with spectrodensitometric detection was developed and validated for the determination of DAN in the presence of DC; it is not only the first HPTLC technique for the determination of DAN in the presence of process-related impurity, but also the first method that includes the synthesis of this impurity with high purity and good yield.
Synthesis of Dantrolene Process Impurity
According to USP, 5-(4-nitrophenyl)-2-furaldehyde was described as DAN related compound C [5] . It is a key precursor for DAN preparation [6] . Also, it is an acidic and a photolytic degradation product of DAN [8, 7] . The synthesis of DC was carried out as shown in Figure 1 . Highly purified product was obtained which was confirmed by several ways:
1. Measuring melting point that was 202-204°C, agreeing with the reported value [20] . Figure 2B) .
(b) IR spectrometry: the IR spectrum ( Figure 2C) shows two characteristic bands at about 1679, indicating carbonyl group; 2850 and 2900, indicating CH aldehydic; and 3400, indicating OH group of absorbed water to which IR spectrophotometer is sensitive.
(c) Mass spectrometry: Mass chart of DC ( Figure 2D ) shows parent peak identified at m/z 217 (corresponding to the molecular weight of DC).
HPTLC-Spectrodensitometric Determination of Dantrolene in the Presence of Its Process Impurity
Thin-layer chromatography (TLC) has made a great progress and it has a wide acceptance as a major tool for both qualitative and quantitative analyses; it has become a well-established method for the assay of drugs in mixtures. HPTLC offers the advantages of automatic application, high separation power, using smaller amount of solvent, and providing dense and compact bands with properly and significantly different retention factor (R f ) values in addition to high sensitivity [21] .
Method Development and Optimization
In order to optimize HPTLC technique, the following variables were tested:
Developing System
Different developing systems of different compositions and ratios were tried such as chloroform-methanol (10:1, by volume), (10:0.5, by volume), chloroform-methanol-glacial acetic acid (10:0.5:0.1, by volume), chloroform-acetone-glacial acetic acid (10:0.3:0.01, by volume), and chloroform-ethyl acetateglacial acetic (10:0.5:0.01, by volume). The best developing system was found to be chloroform-ethyl acetate-glacial acetic (10:0.5:0.01, by volume), where the good separation between DAN and DC was shown by the difference in the R f values and symmetrical peaks; the R f values were 0.22 ± 0.01 for DAN and 0.83 ± 0.01 for DC as shown in Figure 3 . The presence of glacial acetic acid in the developing system is essential for the separation and prevention of DAN tailing.
Scanning Wavelength
Different scanning wavelengths were tried (254, 350, and 380 nm) in order to enhance the sensitivity of the method, where scanning at 380 nm gave the best sensitivity for the studied components. The peaks were sharp, well separated, and symmetrical with minimum noise, as shown in Figure 3 .
Band Dimensions and Slit Dimensions of Scanning Lightbeam
The band width and interspaces between bands should be selected carefully to avoid the spread of bands outside the tracks and interference between adjacent bands [21] . Different band dimensions were tried to obtain sharp and symmetrical peaks. The optimum band width chosen was 5 mm, and the interspace between bands was 5 mm. Moreover, different slit dimensions were tried where 6.00 × 0.3 mm, Micro, proved to be the slit dimensions of choice which provided the highest sensitivity.
The method offered high sensitivity and selectivity for the analysis of DAN in the presence of DC. A relationship between the integrated peaks area × 10 −4 versus the concentrations of DAN and DC in the range of 0.1-1.5 μg band −1 and 0.1-2.0 μg band −1 for DAN and DC, respectively, is shown in Table 1 ; the regression equations were computed using polynomial order as shown in Figure 4 and found to be:
where A is the integrated peak area ×10 −4 , C is the concentrations in μg band −1 , and r is the correlation coefficient. Regression equation parameters are given in Table 1 . The validity of the proposed methods for the analysis of DAN was studied by assaying Dantrelax ® capsules ( Figure 5 and Table 2 ). It was further assessed by applying standard addition technique, which showed that there was no interference from excipients ( Table 2 ).
Method Validation
Method validation was carried out according to the International Conference on Harmonization (ICH) guidelines [22] . 
Linearity
Under optimum experimental conditions, the linearity of DAN and DC was evaluated by analyzing several concentrations determined in duplicates ranging between 0.1-1.5 μg band −1 and 0.1-2.0 μg band −1 for DAN and DC, respectively; working ranges and regression equations parameters are listed in Table 1 . The correlation coefficient near to the unit, besides residuals mean, equals zero (Table 1) , and random pattern of residual plots (Figure 6 ) proved the goodness of the regression equation.
Accuracy
The accuracy of the method was assured by applying the developing method for the determination of different concentrations of pure DAN and DC samples and then applying the corresponding regression equations (the results, given in Table 1 , confirmed the good accuracy of the reported method). The accuracy of the method was also checked by applying the standard addition technique, involving analysis of marketed samples (Dantrelax ® capsules) to which certain amounts of pure DAN were added. The resulting mixtures were assayed, and recoveries (%) were calculated. Good recoveries were obtained, confirming the good accuracy of the proposed method and revealing no interference from excipients, as shown in Table 2 . 0.1-1.5 μg band -1 for DAN and 0.1-2.0 μg band -1 for DC. a) Following a polynomial regression, A = aX 2 + bX + C, where A is the integrated peak area, X is the concentration in μg band −1 , a and b are coefficients 1 and 2, respectively, and C is the intercept b) LOD = 3.3 × SD/slope c) LOQ = 10 × SD/slope Table 2 Determination of dantrolene in the presence of its process impurity in its pharmaceutical formulation by the proposed method and application of a standard addition technique. 
Dantrelax ® capsules
Precision
Precision was studied with respect to both repeatability and intermediate precision.
Repeatability
Three concentrations (0.5, 0.8, and 1.0 µg band −1 ) of DAN and (0.4, 0.6, 1.0 µg band −1 ) of DC were determined in triplicates on the same day to estimate intra-day variation. Acceptable relative standard deviation (RSD %) values were obtained, confirming the repeatability of the method as given in Table 1 .
Intermediate Precision
The previous procedure was repeated on the same concentrations on three different days to determine the intermediate precision. Acceptable RSD % values were obtained as shown in Table 1 .
Limits of Detection and Quantitation (LOD and LOQ)
LOD and LOQ have been calculated for DAN and DC using ICH equations [22] . The low values of both LOD and LOQ indicated the high sensitivity of the developed methods (Table 1) .
Robustness
Robustness measures the capacity to remain unaffected by minor deliberate variations in the method parameters and indicates the reliability of the method under normal usage conditions. The proposed method was found to be robust where deliberate minor changes in the studied chromatographic conditions (e.g., change in ethyl acetate amount ±0.05, chloroform ±0.2 and saturation time ±5 min) did not lead to significant changes
in the R f values. However, concentration of glacial acetic acid proved to be critical where, upon decreasing or increasing its amount ±0.01, dramatic changes in R f values, and hence, chromatographic resolution occurred (Table 1) .
System Suitability
System suitability tests are a fundamental part of liquid chromatographic analyses according to ICH. They determine whether the operating systems were performing properly for the intended analysis. System suitability testing parameters for the developed method were calculated, and acceptable results were obtained as shown in Table 3 . Table 3 System suitability testing parameters of the proposed method for the determination of dantrolene in the presence of its process impurity. The results obtained by the proposed method were statistically compared with those obtained by the reported BP HPLC method [1] using student's t-and F-tests at p < 0.05. The obtained values are less than the theoretical ones, indicating that there is no significant difference between the proposed methods and the reported method. This statistical comparison clarifies the proposed method and is as precise and accurate as the reported method (Table 4) . Table 4 Statistical comparison of the results obtained by the proposed method and the reported method in BP for the determination of dantrolene in the presence of its process impurity.
Parameter
Parameter HPTLC-densitometric method 
Conclusion
The proposed work involved simple, economic, and safe synthesis for DAN process-related impurity. Furthermore, the main advantages of the proposed HPTLC method are high sensitivity and selectivity. Dantrolene and its impurity were determined in the range starting from 0.1 μg mL −1 (Table 1) , while in other HPLC method, determination started from 0.5 μg mL −1 [8] , in addition to the high resolution (R = 4.679) mentioned in Table  3 , besides using one single scanning wavelength for the two studied compounds, saving time and effort, and running several samples simultaneously using a small quantity of developing system. On the other hand, the application of this method to a pharmaceutical preparation showed that the excipients did not interfere with the determination of the studied drug. Finally, the suggested method is simple, accurate, rapid, highly sensitive, and reproducible; hence, it can be used for routine and quality control analysis either in bulk powder or in pharmaceutical formulations.
